Research progress on the role of efferocytosis in liver diseases.
- Author:
Kaixin WANG
1
;
Hui LI
2
;
Haijian DONG
1
;
Qun NIU
1
;
Xikun YANG
1
;
Xiaoyan ZENG
1
;
Xuan WU
1
Author Information
1. Central Laboratory, Chengdu University of TCM, School of Clinical Medicine, Chengdu University of TCM, Chengdu 610072, China.
2. Central Laboratory, Chengdu University of TCM, Chengdu 610072, China. *Corresponding author, E-mail: 1400124746@qq.com.
- Publication Type:English Abstract
- MeSH:
Humans;
Liver Diseases/metabolism*;
Animals;
Phagocytosis/physiology*;
Phagocytes;
Efferocytosis
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(1):71-76
- CountryChina
- Language:Chinese
-
Abstract:
Efferocytosis refers to the process of phagocytes engulfing and clearing the cells after programmed cell death. In recent years, an increasing number of studies have shown that the mechanisms of efferocytosis are closely related to drug-induced liver injury, hepatic ischemia-reperfusion injury, viral hepatitis, cholestatic liver diseases, metabolic-associated fatty liver disease, alcoholic liver disease, and other liver disorders. This review summarized the research progress on the role of efferocytosis in liver diseases, with the hope of providing new targets for the prevention and treatment of liver diseases.
